Items

Patient A

Patient B

Patient C

Patient D

Age

29

33

39

42

Gender

Female

Female

Female

Female

Occupation

Housewife

Housewife

Care worker

Contracted worker

Time living with Type 1 diabetes (years)

4 years

10 years

11 years

4 years

CSII introduction period (years)

3 years

0.5 years

8 years

1 years

MDI introduction period (years)

1 year

9.5 years

3 years

3 years

Blood glucose levels

100 - 150 mg/dl

200 - 250 mg/dl

130 - 150 mg/dl

120 - 160 mg/dl

Location where the patient received the insulin injection (MDI)

Home

Home

Home and the restroom of her office

Home and the restroom of her office

HbA1c (NGSP) prior to CSII introduction

The 9% first half

The 9% first half

The 9% first half

The 7%last half

HbA1c (NGSP) after CSII introduction

The 7% first half

The 8% first half

The 7% last half

The 7% first half

Reasons for switching from MDI therapy to CSII therapy

Due to pregnancy, was recommended by a doctor to switch.

Due to the desire to become pregnant, consulted with a doctor and switched to CSII.

Could not inject during work and there were many incidences of hypoglycemia, so desired to switch to CSII.

Was recommended by a doctor since HbA1c levels did not drop with insulin injections.

Complication of diabetes

No

No

No

No